PureDCA is a new cancer treatment drug that has been proven to shrink cancer tumors by up to 70% in 3 weeks. This drug is used by Medicor Cancer Center in Toronto and by the University of Alberta. PureDCA is packaged in a certified clean room under black light and contains a special oxygen absorbing dessicant packet to maintain its potentency.